In line with our results, there is an emerging line of research that supports the role of the cognitive reserve and the BDNF/TrkB signaling pathway as compensatory responses that delay symptomatology in the early stage of Alzheimer's disease but cannot prevent neurodegeneration in more advanced phases16,80–82. This evidence concerns the gene NTRK2 and Alzheimer disease.